Command Palette

Search for a command to run...

Clinical Trials · NCT02736435

Treatment of Uterine Fibroids With Magnetic Resonance Guided High Intensity Focused Ultrasound

WithdrawnPhase 3Gonadorelin (Prohibited)
Phase
Phase 3
Recruitment status
Withdrawn
Sponsor
Thunder Bay Regional Health Research Institute
Enrollment
0
Start date
Jan 2018
Locations
1 site, Canada
Primary endpoint
Change in uterine fibroid symptom severity scale
View Gonadorelin compound reference